William Mark Dukes - 01 Mar 2024 Form 4 Insider Report for Physicians Realty Trust

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Mar 2024, 16:06:47 UTC
Prior SEC filing
22 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher M. Bartoli, as attorney-in-fact

Key filing fact

William Mark Dukes filed Form 4 for Physicians Realty Trust on 01 Mar 2024.

Key facts

  • This page summarizes William Mark Dukes's Form 4 filing for Physicians Realty Trust.
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 01 Mar 2024, 16:06.

Change

  • Previous filing in this sequence was filed on 22 Jan 2024.
  • Current net transaction value: -$457,768.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DOC transaction

Common shares, $0.01 par value

Options Exercise

Transaction value
Shares
+36,837
Change %
+101%
Price
Shares after
73,321
Date
01 Mar 2024
Ownership
Direct
Footnotes
F1
DOC transaction

Common shares, $0.01 par value

Options Exercise

Transaction value
Shares
+44,235
Change %
+60%
Price
Shares after
117,556
Date
01 Mar 2024
Ownership
Direct
Footnotes
F2
DOC transaction

Common shares, $0.01 par value

Tax liability

Transaction value
$457,768
Shares
-40,763
Change %
-35%
Price
$11.23
Shares after
76,793
Date
01 Mar 2024
Ownership
Direct
DOC transaction

Common shares, $0.01 par value

Disposed to Issuer

Transaction value
Shares
-76,793
Change %
-100%
Price
Shares after
0
Date
01 Mar 2024
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DOC transaction Derivative

2022 Performance Based Restricted Share Unit Grant

Options Exercise

Transaction value
$0
Shares
-12,279
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Mar 2024
Ownership
Direct
Underlying class
Common shares, $0.01 par value
Underlying amount
12,279
Exercise price
Footnotes
F4
DOC transaction Derivative

2023 Performance Based Restricted Share Unit Grant

Options Exercise

Transaction value
$0
Shares
-14,745
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Mar 2024
Ownership
Direct
Underlying class
Common shares, $0.01 par value
Underlying amount
14,745
Exercise price
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

William Mark Dukes is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

Represents vesting of the 2022 Performance Based Restricted Share Units granted on March 1, 2022 under the Issuer's Equity Incentive Plan (the "Plan"). The grant vested on March 1, 2024 pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak Properties, Inc. ("Healthpeak"), DOC DR Holdco, LLC and DOC DR LLC. The Company merged with and into DOC DR Holdco, LLC on March 1, 2024. Pursuant to the terms of the Merger Agreement, the Reporting Person received 36,837 common shares upon vesting, 300% of the target shares.

Footnote F2

Represents vesting of the 2023 Performance Based Restricted Share Units granted on March 1, 2023 under the the Plan. Pursuant to the terms of the Merger Agreement, the Reporting Person received 44,235 common shares upon vesting, 300% of the target shares.

Footnote F3

Represents securities disposed of pursuant to the terms of the the Merger Agreement and each issued and outstanding common shares of the Issuer, held by the reporting person was automatically converted into the right to receive 0.674 of a share of Healthpeak common stock, subject to any adjustment, without interest.

Footnote F4

On March 1, 2022, the Reporting Person was granted 12,279 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 36,837 common shares upon vesting.

Footnote F5

On March 1, 2023, the Reporting Person was granted 14,745 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 44,235 common shares upon vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .